Is it easy to take pemetinib/pemetinib?

Pemigatinib/The treatment cycle of Pemigatinib is designed to be a 21-day cycle. Patients take the medication regularly for the first two weeks of each cycle, followed by a week off medication. The specific duration of medication should be determined by the doctor based on the patient's specific condition. For patients with cholangiocarcinoma (CCA), the recommended dose of pemetinib is 13.5 mg daily for 14 days followed by 7 days off. For patients with FGFR1-rearranged myeloid/lymphoid tumors, the recommended dose is also 13.5 mg per day, but they need to be taken continuously until the disease progresses or the drug side effects are unacceptable.